Research Library — Page 8 | Reta Compare
402 research articles. Page 8 of 17.
Articles
- Retatrutide's Impact on Weight and Metabolic Markers: A Systematic Review
- Retatrutide Efficacy in Weight Loss: Insights from a Systematic Review
- Exploring Retatrutide's Role in Incretin-Based Therapy for Obesity Management
- Exploring the Role of Retatrutide in GLP-1RA Efficacy for Type 2 Diabetes and Obesity
- Exploring Retatrutide: A Triple Agonist for Effective Weight Management
- Evaluating the Cardiovascular Impact of Retatrutide in Type 2 Diabetes Management
- Retatrutide: A Comprehensive Overview of Its Role in Anti-Obesity Treatment
- Exploring the Role of Retatrutide in Weight Loss and Muscle Preservation
- Exploring Retatrutide's Role in Addressing Obesity, NAFLD, and Cardiovascular Diseases
- Exploring Retatrutide: A Triple Agonist in Type 2 Diabetes Management
- Exploring the Role of Retatrutide in Binge Eating Disorder Treatment
- Retatrutide's Efficacy in Weight Loss and Diabetes Management: A Comparative Analysis
- Exploring the Triple Agonism of Retatrutide at GLP-1R, GIPR, and GCGR
- Retatrutide's Impact on Liver Fat in Metabolic Dysfunction-Associated Steatotic Liver Disease
- Demographic Insights from Clinical Trials of Retatrutide and Obesity Medications
- Exploring the Role of Retatrutide in Gut Hormone-Mediated Appetite Regulation
- Exploring Retatrutide: Insights from Recent Developments in GLP-1 Receptor Agonists
- Exploring Retatrutide: A Promising Agent in Obesity Management
- Retatrutide: A Novel Triple Agonist for Obesity Management
- Exploring Retatrutide's Role in Weight Management and Primary Care Insights
- Exploring the Role of Retatrutide in Managing Rare Genetic Obesity in Youth
- Exploring Retatrutide: Advances in Peptide Therapies for Obesity and Diabetes
- Retatrutide: Insights into the Efficacy of Triple Agonists in Obesity Management
- Exploring Retatrutide: A Promising Agent in the Fight Against Obesity
- Exploring Retatrutide's Role in Obesity Treatment through GLP-1 Receptor Binding